Continuus Pharmaceuticals
Pharmaceuticals, 25-R Olympia Avenue, Woburn, , 1801, Massachusetts, United States, 51-200 Employees
Phone Number: 78********
Who is CONTINUUS PHARMACEUTICALS
CONTINUUS mission is to produce high-quality drugs that can be delivered to patients more effectively and at a lower cost. In achieving this goal, we look to radically transform the pharm...
Read More
-
Headquarters: 25-R Olympia Avenue, Woburn, Massachusetts, 1801, United States
-
Date Founded: 2012
-
Employees: 51-200
-
Revenue: $10 Million to $25 Million
-
Active Tech Stack: See technologies
Industry: Pharmaceuticals
SIC Code: 7372
|
NAICS Code: 513210 |
Show More
Does something look wrong? Fix it. | View contact records from CONTINUUS PHARMACEUTICALS
CONTINUUS Pharmaceuticals Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding CONTINUUS Pharmaceuticals
Answer: CONTINUUS Pharmaceuticals's headquarters are located at 25-R Olympia Avenue, Woburn, , 1801, Massachusetts, United States
Answer: CONTINUUS Pharmaceuticals's phone number is 78********
Answer: CONTINUUS Pharmaceuticals's official website is https://continuuspharma.com
Answer: CONTINUUS Pharmaceuticals's revenue is $10 Million to $25 Million
Answer: CONTINUUS Pharmaceuticals's SIC: 7372
Answer: CONTINUUS Pharmaceuticals's NAICS: 513210
Answer: CONTINUUS Pharmaceuticals has 51-200 employees
Answer: CONTINUUS Pharmaceuticals is in Pharmaceuticals
Answer: CONTINUUS Pharmaceuticals contact info: Phone number: 78******** Website: https://continuuspharma.com
Answer: CONTINUUS mission is to produce high-quality drugs that can be delivered to patients more effectively and at a lower cost. In achieving this goal, we look to radically transform the pharmaceutical manufacturing industry, steering it away from outdated batch systems to state-of-the-art continuous processes. CONTINUUS is leveraging a novel continuous manufacturing platform called Integrated Continuous Manufacturing (ICM), initially developed through an $85 M joint research project between Novartis and MIT. With ICM, we will improve affordability and accessibility of pharmaceuticals on a global scale. Our work is critical because the current manufacturing systems are time- and cost-inefficient, and are beset with quality problems. It is not unusual for manufacturing lead times, from start to finish, to be over one year, and studies have shown that the industry loses over $50 B annually due to wasteful processes. More importantly, these problems impact patient care. Hundreds of drugs are placed on the US FDA drug shortage website, many of which are life-saving (e.g., oncology drugs). To solve these problems, we offer a number of solutions. To achieve our goals, CONTINUUS has assembled a team of talented engineers and scientists, with skills ranging from analytical chemistry to drug formulation. Rather than producing medicines through batch-wise, step-by-step processes, ICM allows for fully continuous and automated operations, where the synthesis of the active ingredient and the final dosage form are integrated into a seamless process. This novel method will allow on-demand manufacturing of pharmaceuticals, improving affordability and accessibility of pharmaceuticals on a global scale.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month